XML 84 R15.htm IDEA: XBRL DOCUMENT

Other Income, Net

12 Months Ended

Mar. 31, 2020

Other Nonoperating Income (Expense) [Abstract]



	Years Ended March 31,
(In millions)	2020			2019		2018
Interest income	$	49		$	39	$	48
Equity in earnings, net ⁽¹⁾	36			43		32
Gain from sale of equity investment ⁽²⁾	—			56		43
Actuarial losses from pension plans ⁽³⁾	(127		)	—		—
Other, net	54			44		7
Total	$	12		$	182	$	130


(1)	Primarily recorded within the Company’s European Pharmaceutical Solutions segment.


(2)	Amount represented a pre-tax gain from the sale of an equity investment to a third party included in Other during 2019 and in our U.S. Pharmaceutical and Specialty Solutions segment during 2018.

(3)

Includes $116 million from the termination of the U.S. defined benefit pension plan and $11 million related to a settlement from the executive benefit retirement plan for a recently retired executive. Refer to Financial Note 17, “Pension Benefits.”